Multidimensional  ||| S:0 E:17 ||| NNP
Fatigue  ||| S:17 E:25 ||| NNP
Inventory ||| S:25 E:34 ||| NNP
:  ||| S:34 E:36 ||| :
Spanish  ||| S:36 E:44 ||| JJ
adaptation  ||| S:44 E:55 ||| NN
and  ||| S:55 E:59 ||| CC
psychometric  ||| S:59 E:72 ||| JJ
properties  ||| S:72 E:83 ||| NNS
for  ||| S:83 E:87 ||| IN
fibromyalgia  ||| S:87 E:100 ||| JJ
patients ||| S:100 E:108 ||| NNS
.  ||| S:108 E:110 ||| .
The  ||| S:110 E:114 ||| DT
Al-Andalus  ||| S:114 E:125 ||| JJ
study  ||| S:125 E:131 ||| NN
The  ||| S:131 E:135 ||| DT
aim  ||| S:135 E:139 ||| NN
of  ||| S:139 E:142 ||| IN
this  ||| S:142 E:147 ||| DT
study  ||| S:147 E:153 ||| NN
was  ||| S:153 E:157 ||| VBD
to  ||| S:157 E:160 ||| TO
assess  ||| S:160 E:167 ||| VB
the  ||| S:167 E:171 ||| DT
psychometric  ||| S:171 E:184 ||| JJ
properties  ||| S:184 E:195 ||| NNS
and  ||| S:195 E:199 ||| CC
transcultural  ||| S:199 E:213 ||| JJ
adaptation  ||| S:213 E:224 ||| NN
into  ||| S:224 E:229 ||| IN
Spanish  ||| S:229 E:237 ||| JJ
of  ||| S:237 E:240 ||| IN
the  ||| S:240 E:244 ||| DT
Multidimensional  ||| S:244 E:261 ||| NNP
Fatigue  ||| S:261 E:269 ||| NNP
Inventory  ||| S:269 E:279 ||| NNP
in  ||| S:279 E:282 ||| IN
fibromyalgia  ||| S:282 E:295 ||| JJ
patients ||| S:295 E:303 ||| NNS
.  ||| S:303 E:305 ||| .
The  ||| S:305 E:309 ||| DT
Spanish  ||| S:309 E:317 ||| JJ
version  ||| S:317 E:325 ||| NN
of  ||| S:325 E:328 ||| IN
the  ||| S:328 E:332 ||| DT
Multidimensional  ||| S:332 E:349 ||| NNP
Fatigue  ||| S:349 E:357 ||| NNP
Inventory  ||| S:357 E:367 ||| NNP
( ||| S:367 E:368 ||| -LRB-
MFI-S ||| S:368 E:373 ||| NNP
)  ||| S:373 E:375 ||| -RRB-
was  ||| S:375 E:379 ||| VBD
translated  ||| S:379 E:390 ||| VBN
and  ||| S:390 E:394 ||| CC
cognitively  ||| S:394 E:406 ||| JJ
pretested  ||| S:406 E:416 ||| NNS
following  ||| S:416 E:426 ||| VBG
cross-cultural  ||| S:426 E:441 ||| JJ
adaptation  ||| S:441 E:452 ||| NN
guidelines ||| S:452 E:462 ||| NNS
.  ||| S:462 E:464 ||| .
Test-retest  ||| S:464 E:476 ||| JJ
reliability ||| S:476 E:487 ||| NN
,  ||| S:487 E:489 ||| ,
convergent  ||| S:489 E:500 ||| JJ
validity ||| S:500 E:508 ||| NN
,  ||| S:508 E:510 ||| ,
and  ||| S:510 E:514 ||| CC
operational  ||| S:514 E:526 ||| JJ
qualities  ||| S:526 E:536 ||| NNS
were  ||| S:536 E:541 ||| VBD
evaluated  ||| S:541 E:551 ||| VBN
in  ||| S:551 E:554 ||| IN
a  ||| S:554 E:556 ||| DT
total  ||| S:556 E:562 ||| NN
of  ||| S:562 E:565 ||| IN
116  ||| S:565 E:569 ||| CD
fibromyalgia  ||| S:569 E:582 ||| CD
patients ||| S:582 E:590 ||| NNS
.  ||| S:590 E:592 ||| .
Convergent  ||| S:592 E:603 ||| JJ
validity  ||| S:603 E:612 ||| NN
was  ||| S:612 E:616 ||| VBD
assessed  ||| S:616 E:625 ||| VBN
comparing  ||| S:625 E:635 ||| VBG
MFI-S  ||| S:635 E:641 ||| JJ
with  ||| S:641 E:646 ||| IN
a  ||| S:646 E:648 ||| DT
visual  ||| S:648 E:655 ||| JJ
analogue  ||| S:655 E:664 ||| JJ
scale  ||| S:664 E:670 ||| NN
for  ||| S:670 E:674 ||| IN
global  ||| S:674 E:681 ||| JJ
fatigue ||| S:681 E:688 ||| NN
.  ||| S:688 E:690 ||| .
The  ||| S:690 E:694 ||| DT
intra-class  ||| S:694 E:706 ||| JJ
correlation  ||| S:706 E:718 ||| NN
coefficients  ||| S:718 E:731 ||| VBZ
varied  ||| S:731 E:738 ||| VBN
from  ||| S:738 E:743 ||| IN
moderate  ||| S:743 E:752 ||| JJ
to  ||| S:752 E:755 ||| TO
excellent  ||| S:755 E:765 ||| JJ
( ||| S:765 E:766 ||| -LRB-
from  ||| S:766 E:771 ||| IN
0.64  ||| S:771 E:776 ||| CD
to  ||| S:776 E:779 ||| TO
0.91 ||| S:779 E:783 ||| CD
)  ||| S:783 E:785 ||| -RRB-
and  ||| S:785 E:789 ||| CC
the  ||| S:789 E:793 ||| DT
standard  ||| S:793 E:802 ||| JJ
errors  ||| S:802 E:809 ||| NNS
of  ||| S:809 E:812 ||| IN
the  ||| S:812 E:816 ||| DT
mean  ||| S:816 E:821 ||| VBP
ranged  ||| S:821 E:828 ||| VBN
from  ||| S:828 E:833 ||| IN
0.5  ||| S:833 E:837 ||| CD
to  ||| S:837 E:840 ||| TO
1.1  ||| S:840 E:844 ||| CD
points  ||| S:844 E:851 ||| NNS
for  ||| S:851 E:855 ||| IN
the  ||| S:855 E:859 ||| DT
five  ||| S:859 E:864 ||| CD
MFI-S  ||| S:864 E:870 ||| JJ
domains ||| S:870 E:877 ||| NN
.  ||| S:877 E:879 ||| .
The  ||| S:879 E:883 ||| DT
coefficient  ||| S:883 E:895 ||| NN
of  ||| S:895 E:898 ||| IN
repeatability  ||| S:898 E:912 ||| NN
was  ||| S:912 E:916 ||| VBD
less  ||| S:916 E:921 ||| JJR
than  ||| S:921 E:926 ||| IN
2  ||| S:926 E:928 ||| CD
standard  ||| S:928 E:937 ||| JJ
deviations  ||| S:937 E:948 ||| NNS
and  ||| S:948 E:952 ||| CC
the  ||| S:952 E:956 ||| DT
limits  ||| S:956 E:963 ||| NNS
of  ||| S:963 E:966 ||| IN
agreement  ||| S:966 E:976 ||| NN
ranged  ||| S:976 E:983 ||| VBD
from  ||| S:983 E:988 ||| IN
2  ||| S:988 E:990 ||| CD
to  ||| S:990 E:993 ||| TO
4  ||| S:993 E:995 ||| CD
points  ||| S:995 E:1002 ||| NNS
for  ||| S:1002 E:1006 ||| IN
the  ||| S:1006 E:1010 ||| DT
MFI-S  ||| S:1010 E:1016 ||| JJ
domains ||| S:1016 E:1023 ||| NN
.  ||| S:1023 E:1025 ||| .
A  ||| S:1025 E:1027 ||| DT
weak  ||| S:1027 E:1032 ||| JJ
to  ||| S:1032 E:1035 ||| TO
fair  ||| S:1035 E:1040 ||| JJ
significant  ||| S:1040 E:1052 ||| JJ
relationship  ||| S:1052 E:1065 ||| NN
was  ||| S:1065 E:1069 ||| VBD
found  ||| S:1069 E:1075 ||| VBN
between  ||| S:1075 E:1083 ||| IN
each  ||| S:1083 E:1088 ||| DT
MFI-S  ||| S:1088 E:1094 ||| JJ
domain  ||| S:1094 E:1101 ||| NN
and  ||| S:1101 E:1105 ||| CC
the  ||| S:1105 E:1109 ||| DT
visual  ||| S:1109 E:1116 ||| JJ
analogue  ||| S:1116 E:1125 ||| JJ
scale  ||| S:1125 E:1131 ||| NN
( ||| S:1131 E:1132 ||| -LRB-
from  ||| S:1132 E:1137 ||| IN
0.21  ||| S:1137 E:1142 ||| CD
to  ||| S:1142 E:1145 ||| TO
0.32 ||| S:1145 E:1149 ||| CD
) ||| S:1149 E:1150 ||| -RRB-
.  ||| S:1150 E:1152 ||| .
The  ||| S:1152 E:1156 ||| DT
mean  ||| S:1156 E:1161 ||| JJ
time  ||| S:1161 E:1166 ||| NN
required  ||| S:1166 E:1175 ||| VBN
to  ||| S:1175 E:1178 ||| TO
complete  ||| S:1178 E:1187 ||| VB
the  ||| S:1187 E:1191 ||| DT
MFI-S  ||| S:1191 E:1197 ||| NN
was  ||| S:1197 E:1201 ||| VBD
3.2Â±2.0  ||| S:1201 E:1209 ||| CD
minutes ||| S:1209 E:1216 ||| NNS
.  ||| S:1216 E:1218 ||| .
None  ||| S:1218 E:1223 ||| NN
of  ||| S:1223 E:1226 ||| IN
the  ||| S:1226 E:1230 ||| DT
patients  ||| S:1230 E:1239 ||| NNS
needed  ||| S:1239 E:1246 ||| VBD
external  ||| S:1246 E:1255 ||| JJ
help  ||| S:1255 E:1260 ||| NN
to  ||| S:1260 E:1263 ||| TO
complete  ||| S:1263 E:1272 ||| VB
the  ||| S:1272 E:1276 ||| DT
MFI-S ||| S:1276 E:1281 ||| JJ
,  ||| S:1281 E:1283 ||| ,
and  ||| S:1283 E:1287 ||| CC
there  ||| S:1287 E:1293 ||| EX
were  ||| S:1293 E:1298 ||| VBD
very  ||| S:1298 E:1303 ||| RB
few  ||| S:1303 E:1307 ||| JJ
missing  ||| S:1307 E:1315 ||| JJ
values ||| S:1315 E:1321 ||| NNS
.  ||| S:1321 E:1323 ||| .
The  ||| S:1323 E:1327 ||| DT
MFI-S  ||| S:1327 E:1333 ||| JJ
developed  ||| S:1333 E:1343 ||| VBN
in  ||| S:1343 E:1346 ||| IN
this  ||| S:1346 E:1351 ||| DT
study  ||| S:1351 E:1357 ||| NN
presents  ||| S:1357 E:1366 ||| VBZ
a  ||| S:1366 E:1368 ||| DT
good  ||| S:1368 E:1373 ||| JJ
reliability  ||| S:1373 E:1385 ||| NN
and  ||| S:1385 E:1389 ||| CC
reasonable  ||| S:1389 E:1400 ||| JJ
construct  ||| S:1400 E:1410 ||| JJ
validity  ||| S:1410 E:1419 ||| NN
for  ||| S:1419 E:1423 ||| IN
Spanish  ||| S:1423 E:1431 ||| JJ
fibromyalgia  ||| S:1431 E:1444 ||| JJ
patients  ||| S:1444 E:1453 ||| NNS
unaffected  ||| S:1453 E:1464 ||| VBN
by  ||| S:1464 E:1467 ||| IN
cognitive  ||| S:1467 E:1477 ||| JJ
dysfunction  ||| S:1477 E:1489 ||| NN
and  ||| S:1489 E:1493 ||| CC
severe  ||| S:1493 E:1500 ||| JJ
depression ||| S:1500 E:1510 ||| NN
.  ||| S:1510 E:1512 ||| .
This  ||| S:1512 E:1517 ||| DT
questionnaire  ||| S:1517 E:1531 ||| NN
is  ||| S:1531 E:1534 ||| VBZ
quick ||| S:1534 E:1539 ||| JJ
,  ||| S:1539 E:1541 ||| ,
easy  ||| S:1541 E:1546 ||| JJ
to  ||| S:1546 E:1549 ||| TO
administer  ||| S:1549 E:1560 ||| VB
and  ||| S:1560 E:1564 ||| CC
interpret ||| S:1564 E:1573 ||| VB
.  ||| S:1573 E:1575 ||| .
